EXCEED ORPHAN
ExCEEd Orphan performed multiple successful launches of rare disease medications in CEE countries.
EXCEED ORPHAN
Social Links:
Industry:
Pharmaceutical
Founded:
2018-01-01
Address:
Prague, Hlavni Mesto Praha, Czech Republic
Country:
Czech Republic
Website Url:
http://www.exceedorphan.com
Total Employee:
11+
Status:
Active
Official Site Inspections
http://www.exceedorphan.com
- Host name: 142.93.174.86
- IP address: 142.93.174.86
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "ExCEEd Orphan"
ExCEEd Orphan – Experts for Orphan Drugs
Let’s work together In depth knowledge of local markets. We possess in depth knowledge of our local markets and profound understanding of all processes related to market entry and …See details»
ExCEEd Orphan announces new organizational structure and …
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in CEE region, announces new organizational structure and related appointments effective July 1 …See details»
About - ExCEEd Orphan
We performed multiple successful launches of rare disease medications in CEE countries over the past 20 years in different therapeutic areas (haematology, immunology, metabolic diseases, nephrology, neurology, etc.).See details»
ExCEEd Orphan - LinkedIn
If you are considering commercialization of your orphan medications in Central & Eastern Europe (120mil. inhabitants) please book a meeting with me during the congress or contact me …See details»
ExCEEd Orphan - Crunchbase Company Profile & Funding
Aug 1, 2022 ExCEEd Orphan performed multiple successful launches of rare disease medications in CEE countries.See details»
ExCEEd Orphan | LinkedIn
ExCEEd Orphan, company dedicated to delivering treatments for rare disease patients in 17 countries of Central & Eastern Europe, joined celebration of 20th anniversary of DEBRA …See details»
ExCEEd Orphan SRO - Drug pipelines, Patents, Clinical trials
Explore ExCEEd Orphan SRO with its drug pipeline, therapeutic area, technology platform, .See details»
ExCEEd Orphan: Drug pipelines, Patents, Clinical trials - Synapse
Jul 7, 2023 Explore ExCEEd Orphan with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
Rafa Laboratories to acquire a significant stake in ExCEEd Orphan …
Aug 1, 2022 The worldwide orphan drug market is growing over twice as fast as the non-orphan market, with expected 2021-2026 CAGR of 12%. By 2026, global orphan drug sales are …See details»
Team - ExCEEd Orphan
Jana is a professional finance leader with 10 years experience in pharmaceutical industry and in total 20 years in corporate finance. She started her career in PricewaterhouseCoopers and …See details»
ExCEEd Orphan - Your Pharma Partner
ExCEEd Orphan provides unique full business solution for biopharmaceutical companies launching their medicines in Central & Eastern Europe. ExCEEd Orphan offers a unique blend …See details»
ExCEEd Orphan - Products, Competitors, Financials, Employees ...
About ExCEEd Orphan. ExCEEd Orphan specializes in the commercialization of orphan drugs within the pharmaceutical industry. The company offers services including market access …See details»
ExCEEd Orphan - PitchBook
ExCEEd Orphan General Information Description. Distributor of medical drugs intended to deliver unique medicine to each and every patient with rare diseases. The company offers market …See details»
ExCEEd Orphan - Medhealth Outlook
Www.exceedorphan.com “We possess in depth knowledge of our local markets and profound understanding of all processes related to market entry and commercialization of innovative …See details»
Contact - ExCEEd Orphan
CEE Headquarter. ExCEEd Orphan s.r.o. Bucharova 2657/12 158 00 Prague 5 Czech RepublicSee details»
ExCEEd Orphan s.r.o. announces joining Your Pharma Partner in …
May 21, 2021 ExCEEd Orphan s.r.o. (www.exceedorphan.com), are a Czech-based full business solution provider for Biotechnology and Pharmaceutical companies who are …See details»
Rafa Laboratories to acquire a significant stake in ExCEEd
Aug 1, 2022 The worldwide orphan drug market is growing over twice as fast as the non-orphan market, with expected 2021-2026 CAGR of 12%. By 2026, global orphan drug sales are …See details»
Rafa Laboratories to acquire a significant stake in ExCEEd Orphan …
[email protected] About Rafa Founded in 1937 and headquartered in Jerusalem, Israel, Rafa is among the leading pharmaceutical companies in Israel and a global …See details»
Distribution agreement signed with ExCEEd Orphan for Central …
Oct 14, 2021 For further information about ExCEEd Orphan, please visit www.exceedorphan.com. Date of Preparation: October 2021 Code: CORP-GB-0153. Diurnal …See details»
Solution – ExCEEd Orphan
Proper situational assessment and business planning (demographics, macroeconomics, healthcare system specifics, real market size/No of patients, diagnostic and treatment …See details»